$18.13
0.382.14%
At Close: -
$18.13
00.00%
After Hours: 5:08 PM EDT
15 minutes delayed
ACADIA Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ACADIA Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ACAD | ACADIA Pharmaceuticals | $0.01 | $0.19 | — | — | $165.24M | $236.00M | — | — | 08/05/2024 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.27 | $0.05 | $0.10 | 100.00% | $118.46M | $208.36M | $205.83M | -1.21% | 05/08/2024 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.26 | $0.30 | $0.28 | -6.67% | $136.49M | $223.70M | $231.04M | 3.28% | 02/27/2024 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.17 | -$0.43 | -$0.40 | 6.98% | $130.71M | $189.51M | $211.70M | 11.71% | 11/02/2023 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.21 | -$0.08 | $0.01 | 112.50% | $134.56M | $157.81M | $165.24M | 4.71% | 08/02/2023 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.70 | -$0.21 | -$0.27 | -28.57% | $115.47M | $120.29M | $118.46M | -1.52% | 05/08/2023 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.27 | -$0.24 | -$0.26 | -8.33% | $130.76M | $134.07M | $136.49M | 1.81% | 02/27/2023 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.09 | -$0.18 | -$0.17 | 5.56% | $131.61M | $139.86M | $130.71M | -6.54% | 11/02/2022 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.27 | -$0.25 | -$0.21 | 16.00% | $115.22M | $130.43M | $134.56M | 3.17% | 08/08/2022 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.42 | -$0.60 | -$0.70 | -16.67% | $106.55M | $121.92M | $115.47M | -5.29% | 05/04/2022 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.42 | -$0.24 | -$0.27 | -12.50% | $121.01M | $135.60M | $130.76M | -3.57% | 02/28/2022 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.54 | -$0.26 | -$0.09 | 65.38% | $120.58M | $127.75M | $131.61M | 3.02% | 11/08/2021 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.27 | -$0.31 | -$0.27 | 12.90% | $110.10M | $126.15M | $115.22M | -8.66% | 08/04/2021 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.57 | -$0.53 | -$0.42 | 20.75% | $90.07M | $111.63M | $106.55M | -4.55% | 05/05/2021 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.34 | -$0.47 | -$0.42 | 10.64% | $98.33M | $123.20M | $121.01M | -1.78% | 02/24/2021 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.29 | -$0.38 | -$0.54 | -42.11% | $94.59M | $118.82M | $120.58M | 1.48% | 11/04/2020 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.38 | -$0.44 | -$0.27 | 38.64% | $83.20M | $103.34M | $110.10M | 6.54% | 08/05/2020 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.59 | -$0.48 | -$0.57 | -18.75% | $62.96M | $91.51M | $90.07M | -1.58% | 05/07/2020 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.50 | -$0.36 | -$0.34 | 5.56% | $59.57M | $96.76M | $98.33M | 1.62% | 02/26/2020 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.50 | -$0.40 | -$0.29 | 27.50% | $58.30M | $88.49M | $94.59M | 6.89% | 10/30/2019 | Get Alert |
ACAD | ACADIA Pharmaceuticals | -$0.51 | -$0.45 | -$0.38 | 15.56% | $57.06M | $72.57M | $83.20M | 14.65% | 07/31/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $0.10 | $0.05 | 100.0 % |
Dec 2023 | 2024-02-27 | $0.28 | $0.30 | -6.67 % |
Sep 2023 | 2023-11-02 | $-0.40 | $-0.43 | 6.98 % |
Jun 2023 | 2023-08-02 | $0.01 | $-0.08 | 112.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-08 | $205.83M | $208.36M | -1.21 % |
Dec 2023 | 2024-02-27 | $231.04M | $223.70M | 3.28 % |
Sep 2023 | 2023-11-02 | $211.70M | $189.51M | 11.7 % |
Jun 2023 | 2023-08-02 | $165.24M | $157.81M | 4.71 % |
ACADIA Pharmaceuticals (ACAD) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
The Actual EPS was $0.10, which beat the estimate of $0.05.
The Actual Revenue was $205.8M, which missed the estimate of $208.4M.
Browse earnings estimates, EPS, and revenue on all stocks.